CoChat
Sign Up
Cited by 163Antifungal resistance and susceptibilityYeasts and Rust Fungi StudiesFungal Infections and Studies

The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.

Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris

Open access
Chen, Jingjing, Tian, Sufei, Han, Xiaoxu, Chu, Yunzhuo, Wang, Qihui, Zhou, Baosen, Shang, Hong·2020·BMC Infectious Diseases
DOI 10.1186/s12879-020-05543-0PMC PMC7656719
Open this paper in CoChat — free accountOpen PDF

Abstract

Background: Candida auris is a new pathogen called “superbug fungus” which caused panic worldwide. There are no large-scale epidemiology studies by now, therefore a systematic review and meta-analysis was undertaken to determine the epidemic situation, drug resistance patterns and mortality of C. auris . Methods: We systematically searched studies on the clinical report of Candida auris in Pubmed, Embase and Cochrane databases until October 6, 2019. A standardized form was used for data collection, and then statics was performed with STATA11.0. Results: It showed that more than 4733 cases of C. auris were reported in over 33 countries, with more cases in South Africa, United States of America, India, Spain, United Kingdom, South Korea, Colombia and Pakistan. C. auirs exhibited a decrease in case count after 2016. Clade I and III were the most prevalent clades with more cases reported and wider geographical distribution. Blood stream infection was observed in 32% of the cases, which varied depending on the clades. Resistance to fluconazole, amphotericin B, caspofungin, micafungin and anidulafungin in C. auris were 91, 12, 12.1, 0.8 and 1.1%. The overall mortality of C. auris infection was 39%. Furthermore, subgroup analyses showed that mortality was higher in bloodstream infections (45%), and lower in Europe (20%). Conclusions: Over 4000 cases of C. auris were reported in at least 33 countries, which showed high resistance to fluconazole, moderate resistance to amphotericin B and caspofungin, high sensitivity to micafungin and anidulafungin. The crude mortality for BSI of C. auris was 45% which was similar to some drug-resistant bacteria previously reported. In conclusion, C. auris displayed similar characteristics to some drug resistance organisms. This study depicts several issues of C. auris that are most concerned, and is of great significance for the clinical management.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12879-020-05543-0

Cites

79 of 79 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Global reported cases of C. auris by country (adapted from Robinson projection map). The reported case count of patients with C. auris and clade(s) in different countries were represented in descending order. An epidemic curve showing case count of C. auris by year was also portrayed based on publication data
Fig. 1 Global reported cases of C. auris by country (adapted from Robinson projection map). The reported case count of patients with C. auris and clade(s) in different countries were represented in descending order. An epidemic curve showing case count of C. auris by year was also portrayed based on publication dataCC BY · PubMed Central
Fig. 2 Forest plot on BSI rate of C. auris (a) and subgroup analysis by clade (b). ES: Effect size
Fig. 2 Forest plot on BSI rate of C. auris (a) and subgroup analysis by clade (b). ES: Effect sizeCC BY · PubMed Central
Fig. 3 Forest plot on the drug resistance of C. auris to fluconazole (a) and amphotericin B (b)
Fig. 3 Forest plot on the drug resistance of C. auris to fluconazole (a) and amphotericin B (b)CC BY · PubMed Central
Fig. 4 Forest plot on the crude mortality of C. auris
Fig. 4 Forest plot on the crude mortality of C. aurisCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 79 references

Cited by

Sorted by citations

Items 101–163 of 163

Related

See all

Metadata

Authors
Chen, J., Tian, S., Han, X., Chu, Y., Wang, Q., Zhou, B., & Shang, H.
Affiliations
First Hospital of China Medical University (CN)
Corresponding author
Shang, Hong
ORCID
Venue
BMC Infectious Diseases
Publisher
Springer Science and Business Media LLC
Published
2020-11-11
Volume
20
Issue
1
Pages
827-827
ISSN
1471-2334 (ISSN-L)
DOI
10.1186/s12879-020-05543-0
PMC
PMC7656719
OpenAlex
W3102866798
Cited by
159
References
79
Citations by year
2026: 36 · 2025: 26 · 2024: 30 · 2023: 38 · 2022: 20 · 2021: 9
FWCI
0.79
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Infectious Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Laboratory medicine innovation unit, Chinese Academy of Medical Sciences (2019RU017)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
  • Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords
Candida auris, fungemia, antifungal resistance, fluconazole resistance, amphotericin B resistance, caspofungin resistance, micafungin, anidulafungin, global epidemiology, mortality, emerging fungal pathogens
MeSH terms
Caspofungin, Micafungin, Anidulafungin, Amphotericin B, Antifungal Agents, Candida, Candidiasis, Humans, Fluconazole, Prevalence, Drug Resistance, Multiple, Fungal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review